Loss Of Tumor Suppressor SMAD4 Triggers Widespread Chromosomal Instability
Genetics

Loss Of Tumor Suppressor SMAD4 Triggers Widespread Chromosomal Instability

Researchers discover how losing a key signaling protein stalls DNA replication and causes severe chromosomal chaos in gastrointestinal cancers.

By Elizabeth Taylor
Published:
Email this Article
Loss Of Tumor Suppressor SMAD4 Triggers Widespread Chromosomal Instability
Photo by Steve A Johnson on Unsplash

Loss of a single well-known tumor suppressor gene triggers widespread genetic chaos inside cancer cells by causing DNA replication machinery to collide and stall. Researchers discovered that when human cells lose the tumor suppressor gene known as SMAD4, they suffer from severe genomic instability that drives both structural breaks in chromosomes and whole-chromosome gains or losses.

The study, published in Science Advances by Abhishek Paul and Holger Bastians from the University Medical Center Göttingen along with their international collaborators, sheds light on the mechanical roots of advanced cancer aggressiveness. Chromosomal instability, or the continuous gain, loss, or rearrangement of chromosomes during cell division, is a hallmark of human tumors. It helps cancer evolve toward therapy resistance and metastasis, but the upstream events that initiate this instability have remained poorly understood.

How Does Loss of Chromosome Arm 18q Drive Tumor Evolution?

To pinpoint genomic regions tied to instability, the team analyzed large cancer datasets from The Cancer Genome Atlas focusing on colorectal cancer and pancreatic ductal adenocarcinoma. They evaluated complexity scores measuring structural aberrations and whole-chromosome deviations across hundreds of tumor samples. The deletion of chromosome arm 18q emerged as the most significant large-scale alteration associated with high genomic instability.

Further analysis of genes residing on chromosome 18q revealed that low expression of SMAD4, a well-characterized tumor suppressor located in this region, strongly correlated with high instability scores. SMAD4 is frequently inactivated during the late stages of gastrointestinal cancers through a combination of chromosomal loss and mutations. To test its functional role, the researchers used CRISPR-Cas9 gene editing to knock out SMAD4 in stable human cell lines.

Tracking single-cell clones over thirty generations revealed that eliminating SMAD4 led to a sharp rise in chromosomal breaks and increased chromosome number variability. Conversely, reintroducing SMAD4 into chromosomally unstable cancer cells that endogenously lacked it successfully suppressed these defects.

What Links Replication Stress to Mitotic Errors in Deficient Cells?

The team found that SMAD4 deficiency induces DNA replication stress, a condition where the cellular machinery copying DNA slows down or stalls. Using DNA combing to measure the velocity of individual replication forks, they observed that SMAD4 knockout slowed down fork progression just as direct chemical inhibitors of DNA replication do. This replication stress stemmed from transcription-replication conflicts, where the molecular machinery transcribing genes collides head-on with the machinery copying the genome.

When the researchers temporarily inhibited transcription elongation during the DNA synthesis phase using a drug called DRB, the conflicts resolved and replication fork speed recovered. Alleviating these conflicts also prevented the formation of chromosomal breaks, indicating that transcription-replication collisions directly drive structural instability.

Why Is Bone Morphogenetic Protein Signaling Essential for Genome Guarding?

SMAD4 acts as a central mediator downstream of two major signaling pathways, known as transforming growth factor beta and bone morphogenetic protein. By selectively inhibiting each pathway, the team determined that losing bone morphogenetic protein signaling, rather than transforming growth factor beta signaling, triggered transcription-replication conflicts, replication stress, and chromosomal instability.

Through integrated transcriptomic profiling, the authors identified inhibitor of DNA binding 3, abbreviated as ID3, as a critical downstream target gene regulated by bone morphogenetic protein and SMAD4 signaling. Loss of ID3 phenocopied SMAD4 deficiency, inducing severe replication stress and structural chromosome aberrations. Restoring ID3 in SMAD4-knockout cells rescued normal fork progression and repaired homologous recombination DNA repair efficiency, a vital cellular mechanism for fixing double-strand breaks.

How Do Replication Flaws Spill Over Into Mitotic Division?

Cancer cells typically display both structural chromosome breaks and numerical aneuploidy, where cells end up with incorrect whole chromosome counts. Recent biophysical models suggest that replication stress leaves lingering defects that alter microtubule dynamics during subsequent mitosis, causing chromosomes to missegregate.

Live-cell imaging of microtubule growth tips demonstrated that losing bone morphogenetic protein signaling, SMAD4, or ID3 abnormally accelerated microtubule growth rates within mitotic spindles. These hyperactive growth rates directly correlated with high rates of chromosome missegregation during anaphase. Treating the cells with subnanomolar doses of Taxol, a drug that dampens microtubule dynamics, successfully rescued proper chromosome segregation.

The authors conclude that loss of bone morphogenetic protein, SMAD4, and ID3 signaling impairs homologous recombination and causes transcription-replication conflicts. This sequence of events generates replication stress, disrupts mitotic spindle fidelity, and ultimately drives the dual accumulation of structural and numerical chromosomal instability seen in aggressive late-stage human tumors.

The research was published in Science advances on November 20, 2026.

Fact Checked

This article has been fact checked for accuracy, with information verified against reputable sources. Learn more about us and our editorial process.

Last reviewed on .

Article history

  • Latest version

Cite this page:

Taylor, Elizabeth. “Loss Of Tumor Suppressor SMAD4 Triggers Widespread Chromosomal Instability.” BioScience. BioScience ISSN 2521-5760, 22 November 2026. <https://www.bioscience.com.pk/en/subject/genetics/smad4-loss-drives-cancer-chromosomal-instability-through-transcription-replication-conflict-associated-replication-stress>. Taylor, E. (2026, November 22). “Loss Of Tumor Suppressor SMAD4 Triggers Widespread Chromosomal Instability.” BioScience. ISSN 2521-5760. Retrieved November 22, 2026 from https://www.bioscience.com.pk/en/subject/genetics/smad4-loss-drives-cancer-chromosomal-instability-through-transcription-replication-conflict-associated-replication-stress Taylor, Elizabeth. “Loss Of Tumor Suppressor SMAD4 Triggers Widespread Chromosomal Instability.” BioScience. ISSN 2521-5760. https://www.bioscience.com.pk/en/subject/genetics/smad4-loss-drives-cancer-chromosomal-instability-through-transcription-replication-conflict-associated-replication-stress (accessed November 22, 2026).
End of the article